<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03154034</url>
  </required_header>
  <id_info>
    <org_study_id>UHRegensburg1</org_study_id>
    <nct_id>NCT03154034</nct_id>
  </id_info>
  <brief_title>Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation</brief_title>
  <official_title>Cardiopulmonary Exercise Testing in Severe Mitral Regurgitation - a Single Center, Observational Echocardiographic Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Regensburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Regensburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is the evaluation of cardiac and pulmonary response to&#xD;
      cardiopulmonary exercise in severe mitral regurgitation and its variation under treatment&#xD;
      (surgical mitral valve repair, percutaneous mitral valve repair, optimal medical treatment).&#xD;
      The study is conducted as a prospective, observational, single-center study. Patients&#xD;
      suffering from symptomatic severe mitral regurgitation will be eligible, if they are referred&#xD;
      to the University Hospital of Regensburg, Germany, for further diagnostic procedures and&#xD;
      heart team discussion. Cardiopulmonary exercise testing is performed comprising standardized&#xD;
      stress echocardiography as well as ergospirometry. Additional detailed assessment will be&#xD;
      conducted including standardized questionary, clinical examination, transesophageal&#xD;
      echocardiography and measurement of biomarkers.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 13, 2014</start_date>
  <completion_date type="Actual">August 31, 2018</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>2 Years</target_duration>
  <primary_outcome>
    <measure>exercise-induced systolic pulmonary arterial pressure</measure>
    <time_frame>Change from Baseline Exercise-Induced Systolic Pulmonary Arterial Pressure at 1 year</time_frame>
    <description>exercise-induced systolic pulmonary arterial pressure measured by stress- echocardiography</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>peak oxygen uptake (peakVO2)</measure>
    <time_frame>Change from Baseline peakVO2 at 1 year</time_frame>
    <description>peak oxygen uptake measured by ergospirometry</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">38</enrollment>
  <condition>Mitral Valve Regurgitation</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Severe mitral regurgitation</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood (serum and plasma samples)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Symptomatic, severe mitral regurgitation. Aetiology and treatment of mitral regurgitation&#xD;
        do not affect enrollment.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  symptomatic, severe mitral regurgitation&#xD;
&#xD;
          -  referral for diagnostic work-up and heart team discussion&#xD;
&#xD;
          -  declaration of informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  contra-indication for cardiopulmonary stress examination (unstable angina pectoris,&#xD;
             left main disease, abnormal electrolyte concentrations, acute decompensation)&#xD;
&#xD;
          -  pregnancy&#xD;
&#xD;
          -  exercise test on treadmill not possible (amputation of lower extremity, severe&#xD;
             arthritis of lower extremities)&#xD;
&#xD;
          -  no acceptable acoustic window at rest&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alexander Dietl, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Regensburg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Regensburg - Department of Internal Medicine II</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <link>
    <url>http://www.uniklinikum-regensburg.de/e/departments/internal-medicine-2/index.php</url>
    <description>Study center</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 15, 2017</study_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Regensburg</investigator_affiliation>
    <investigator_full_name>Dr. Alexander Dietl</investigator_full_name>
    <investigator_title>Resident</investigator_title>
  </responsible_party>
  <keyword>Stress echocardiography</keyword>
  <keyword>Cardiopulmonary exercise testing</keyword>
  <keyword>ergospirometry</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Mitral Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

